139 related articles for article (PubMed ID: 19144517)
21. Investigating biological activity spectrum for novel quinoline analogues 2: hydroxyquinolinecarboxamides with photosynthesis-inhibiting activity.
Musiol R; Tabak D; Niedbala H; Podeszwa B; Jampilek J; Kralova K; Dohnal J; Finster J; Mencel A; Polanski J
Bioorg Med Chem; 2008 Apr; 16(8):4490-9. PubMed ID: 18342517
[TBL] [Abstract][Full Text] [Related]
22. Selective inhibition of CBP/p300 HAT.
Sarli V; Giannis A
Chem Biol; 2007 Jun; 14(6):605-6. PubMed ID: 17584607
[TBL] [Abstract][Full Text] [Related]
23. Discovery, Structure-Activity Relationship, and Biological Activity of Histone-Competitive Inhibitors of Histone Acetyltransferases P300/CBP.
Wu F; Hua Y; Kaochar S; Nie S; Lin YL; Yao Y; Wu J; Wu X; Fu X; Schiff R; Davis CM; Robertson M; Ehli EA; Coarfa C; Mitsiades N; Song Y
J Med Chem; 2020 May; 63(9):4716-4731. PubMed ID: 32314924
[TBL] [Abstract][Full Text] [Related]
24. A dual-mode fluorescence strategy for screening HAT modulators.
Xie N; Elangwe EN; Asher S; Zheng YG
Bioconjug Chem; 2009 Feb; 20(2):360-6. PubMed ID: 19146394
[TBL] [Abstract][Full Text] [Related]
25. Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cells.
Lenoci A; Tomassi S; Conte M; Benedetti R; Rodriguez V; Carradori S; Secci D; Castellano S; Sbardella G; Filetici P; Novellino E; Altucci L; Rotili D; Mai A
ChemMedChem; 2014 Mar; 9(3):542-8. PubMed ID: 24504685
[TBL] [Abstract][Full Text] [Related]
26. Reactivity of isothiazolones and isothiazolone-1-oxides in the inhibition of the PCAF histone acetyltransferase.
Ghizzoni M; Haisma HJ; Dekker FJ
Eur J Med Chem; 2009 Dec; 44(12):4855-61. PubMed ID: 19683843
[TBL] [Abstract][Full Text] [Related]
27. Relationship between lunasin's sequence and its inhibitory activity of histones H3 and H4 acetylation.
Hernández-Ledesma B; Hsieh CC; de Lumen BO
Mol Nutr Food Res; 2011 Jul; 55(7):989-98. PubMed ID: 21618425
[TBL] [Abstract][Full Text] [Related]
28. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
[TBL] [Abstract][Full Text] [Related]
29. Novel 5-carboxy-8-HQ based histone demethylase JMJD2A inhibitors: introduction of an additional carboxyl group at the C-2 position of quinoline.
Feng T; Li D; Wang H; Zhuang J; Liu F; Bao Q; Lei Y; Chen W; Zhang X; Xu X; Sun H; You Q; Guo X
Eur J Med Chem; 2015 Nov; 105():145-55. PubMed ID: 26491978
[TBL] [Abstract][Full Text] [Related]
30. Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative.
Ghizzoni M; Boltjes A; Graaf Cd; Haisma HJ; Dekker FJ
Bioorg Med Chem; 2010 Aug; 18(16):5826-34. PubMed ID: 20655754
[TBL] [Abstract][Full Text] [Related]
31. Acetylation of histone deacetylase 6 by p300 attenuates its deacetylase activity.
Han Y; Jeong HM; Jin YH; Kim YJ; Jeong HG; Yeo CY; Lee KY
Biochem Biophys Res Commun; 2009 May; 383(1):88-92. PubMed ID: 19344692
[TBL] [Abstract][Full Text] [Related]
32. Curcumin is an inhibitor of p300 histone acetylatransferase.
Marcu MG; Jung YJ; Lee S; Chung EJ; Lee MJ; Trepel J; Neckers L
Med Chem; 2006 Mar; 2(2):169-74. PubMed ID: 16787365
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro.
Liu Y; Zhao Y; Zhai X; Feng X; Wang J; Gong P
Bioorg Med Chem; 2008 Jul; 16(13):6522-7. PubMed ID: 18524601
[TBL] [Abstract][Full Text] [Related]
34. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
Rahim R; Strobl JS
Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel nucleoside derivatives as selective lysine acetyltransferase p300 inhibitors for cancer therapy.
Dai Q; Yuan Z; Sun Q; Ao Z; He B; Jiang Y
Bioorg Med Chem Lett; 2024 May; 104():129742. PubMed ID: 38604299
[TBL] [Abstract][Full Text] [Related]
36. Anti-histone acetyltransferase activity from allspice extracts inhibits androgen receptor-dependent prostate cancer cell growth.
Lee YH; Hong SW; Jun W; Cho HY; Kim HC; Jung MG; Wong J; Kim HI; Kim CH; Yoon HG
Biosci Biotechnol Biochem; 2007 Nov; 71(11):2712-9. PubMed ID: 17986787
[TBL] [Abstract][Full Text] [Related]
37. Discovery of covalent inhibitors for MIF tautomerase via cocrystal structures with phantom hits from virtual screening.
McLean LR; Zhang Y; Li H; Li Z; Lukasczyk U; Choi YM; Han Z; Prisco J; Fordham J; Tsay JT; Reiling S; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6717-20. PubMed ID: 19836948
[TBL] [Abstract][Full Text] [Related]
38. 3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors.
Rivkin A; Kim YR; Goulet MT; Bays N; Hill AD; Kariv I; Krauss S; Ginanni N; Strack PR; Kohl NE; Chung CC; Varnerin JP; Goudreau PN; Chang A; Tota MR; Munoz B
Bioorg Med Chem Lett; 2006 Sep; 16(17):4620-3. PubMed ID: 16784844
[TBL] [Abstract][Full Text] [Related]
39. Discovery and characterization of NK13650s, naturally occurring p300-selective histone acetyltransferase inhibitors.
Tohyama S; Tomura A; Ikeda N; Hatano M; Odanaka J; Kubota Y; Umekita M; Igarashi M; Sawa R; Morino T
J Org Chem; 2012 Oct; 77(20):9044-52. PubMed ID: 22984806
[TBL] [Abstract][Full Text] [Related]
40. Combination Targeting of the Bromodomain and Acetyltransferase Active Site of p300/CBP.
Zucconi BE; Makofske JL; Meyers DJ; Hwang Y; Wu M; Kuroda MI; Cole PA
Biochemistry; 2019 Apr; 58(16):2133-2143. PubMed ID: 30924641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
